Prostate cancer: To scan or not to scan for lymph node involvement?

References

• Gervasi LA, Mata J, Easly JD, Wilbanks JH, Seale-Hawkins C, Carlton CE, et al. Prognostic significance of lymph nodal metastases in prostate cancer. J Urol 1989; 142: 332–6
   PubMed Web of Science ®Google Scholar
• Daneshmand S, Quek ML, Stein JP, Lieskovsky G, Cai J, Pinski J, et al. Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: long-term results. J Urol 2004; 172: 2252–5
   PubMed Web of Science ®Google Scholar
• Tempany CMC, McNiel BJ. Advances in biomedical imaging. JAMA 2001; 285: 562–7
   PubMed Web of Science ®Google Scholar
• Partin AW, Mangold LA, Lamm DM, Walsh PC, Epstein JI, Pearson JD. Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium. Urology 2001; 58: 843–8
   PubMed Web of Science ®Google Scholar
• Borley NC, Fabrin K, Poulsen J, Sriprasad S, Mondaini N, Thompson PM, et al. Laparoscopic pelvic lymph node dissection allows significantly more accurate staging in “high-risk” prostate cancer compared to MRI or CT. Scand J Urol Nephrol 2003; 37: 382–6
   PubMed Web of Science ®Google Scholar
• Huncharek M, Muscat J. Serum prostate-specific antigen as a predictor of staging abdominal/pelvic computed tomography in newly diagnosed prostate cancer. Abdom Imaging 1996; 21: 364–7
   PubMedGoogle Scholar
• Abuzallouf S, Dayes I, Lukka H. Baseline staging of newly diagnosed prostate cancer: a summary of the literature. J Urol 2004; 171: 2122–7
   PubMed Web of Science ®Google Scholar
• Magnusson A, Fritjofsson Å, Norlen BJ, Wicklund H. The value of computed tomography and ultrasound in assessment of pelvic lymph node metastases in patients with clinically locally confined carcinoma of the prostate. Scand J Urol Nephrol 1988; 22: 7–10
   PubMed Web of Science ®Google Scholar
• Wolf JS, Cher M, Dall'era M, Presti JC, Hricak H, Carroll PR. Prostate cancer: the use and accuracy of cross-sectional imaging and fine needle aspiration cytology for detection of pelvic lymph node metastases before radical prostatectomy. J Urol 1995; 153: 993–9
   PubMed Web of Science ®Google Scholar
• Bader P, Burkhart FC, Markwalder R, Studer UE. Is a limited lymph node dissection an adequate staging procedure for prostate cancer?. J Urol 2002; 168: 514–8
   PubMed Web of Science ®Google Scholar
• Burkhard FC, Studer UE. The role of lymphadenectomy in prostate cancer. Urol Oncol 2004; 22: 198–202
   PubMed Web of Science ®Google Scholar
• Burkhart FC, Schumacher M, Thalmann GN, Studer UE. Is pelvic lymphadenectomy really necessary in patients with a serum prostate-specific antigen level of <10 ng/mL undergoing radical prostatectomy for prostate cancer?. BJU Int 2005; 95: 275–8
   PubMed Web of Science ®Google Scholar
• Allaf ME, Palapattu GS, Trock BJ, Carter HB, Walsh PC. Anatomical extent of lymph node dissection: impact on men with clinically localized prostate cancer. J Urol 2004; 172: 1840–4
   PubMed Web of Science ®Google Scholar
• Heidenreich A, Varga Z, von Knobloch R. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis. J Urol 2002; 167: 1681–6
   PubMed Web of Science ®Google Scholar
• Tiguert R, Gheiler EL, Tefilli MV, Oskanian P, Banerjee M, Grignon DJ, et al. Lymph node size does not correlate with the presence of prostate cancer metastasis. Urology 1999; 53: 367–71
   PubMed Web of Science ®Google Scholar
• Jeschke S, Thigarajan N, Leeb K, Ziegerhofer J, Sega W, Janetschek G. Detection of early lymph node metastases in prostate cancer by laparoscopic radioisotope guided sentinel lymph node dissection. J Urol 2005; 173: 1943–6
   PubMed Web of Science ®Google Scholar
• Wawroschek F, Hamm M, Weckermann D, Vogt H, Harzmann R. Lymph node staging in clinically localized prostate cancer. Urol Int 2003; 71: 129–35
   PubMed Web of Science ®Google Scholar
• Schmid DT, John H, Zweifel R, Cservenyak T, Westera G, Goerres GW, et al. Fluorocholine PET/CT in patients with prostate cancer: initial experience. Radiology 2005; 235: 623–8
   PubMed Web of Science ®Google Scholar
• Harisinghani MG, Barentsz J, Hahn PF, Deserno WM, Tabatabaei S, van de Kaa CH, et al. Non-invasive detection of clinically occult lymph node metastases in prostate cancer. N Engl J Med 2003; 348: 2491–9
   PubMed Web of Science ®Google Scholar